

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.70231968 |
| 2 | nuclear pore complex assembly (GO:0051292) | 4.86465070 |
| 3 | nuclear pore organization (GO:0006999) | 4.82208674 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.77989377 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.77989377 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.45913951 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.45913951 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.43536309 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.42830487 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.31780874 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 4.31780874 |
| 12 | response to interleukin-15 (GO:0070672) | 4.27850425 |
| 13 | mitotic sister chromatid cohesion (GO:0007064) | 4.19705773 |
| 14 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.16904957 |
| 15 | lysine catabolic process (GO:0006554) | 4.12582160 |
| 16 | lysine metabolic process (GO:0006553) | 4.12582160 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 4.01977143 |
| 18 | megakaryocyte development (GO:0035855) | 3.93346176 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93092431 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.85340516 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.85340516 |
| 22 | positive regulation of granulocyte differentiation (GO:0030854) | 3.85253341 |
| 23 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.82871876 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 3.81508767 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 3.77563199 |
| 26 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.71449292 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70502013 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65123373 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 3.64757918 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.62319508 |
| 31 | cysteine metabolic process (GO:0006534) | 3.60864382 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.56140727 |
| 33 | mitotic G2/M transition checkpoint (GO:0044818) | 3.53999389 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.53096702 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.51871236 |
| 36 | phospholipid scrambling (GO:0017121) | 3.42608982 |
| 37 | urea metabolic process (GO:0019627) | 3.42590286 |
| 38 | urea cycle (GO:0000050) | 3.42590286 |
| 39 | pore complex assembly (GO:0046931) | 3.42240273 |
| 40 | definitive hemopoiesis (GO:0060216) | 3.41273621 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.40619652 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.40060867 |
| 43 | complement activation, alternative pathway (GO:0006957) | 3.38349806 |
| 44 | protein carboxylation (GO:0018214) | 3.36445327 |
| 45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.36445327 |
| 46 | regulation of fibroblast apoptotic process (GO:2000269) | 3.31446376 |
| 47 | regulation of protein activation cascade (GO:2000257) | 3.31061387 |
| 48 | regulation of B cell differentiation (GO:0045577) | 3.30759294 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 3.29193676 |
| 50 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.24501426 |
| 51 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.24501426 |
| 52 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.24501426 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22804595 |
| 54 | regulation of complement activation (GO:0030449) | 3.18447807 |
| 55 | sister chromatid segregation (GO:0000819) | 3.18246449 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16296166 |
| 57 | succinate metabolic process (GO:0006105) | 3.15853387 |
| 58 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.15013124 |
| 59 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.12178864 |
| 60 | interferon-gamma production (GO:0032609) | 3.10901472 |
| 61 | valine metabolic process (GO:0006573) | 3.10724134 |
| 62 | tyrosine metabolic process (GO:0006570) | 3.10596835 |
| 63 | positive regulation of glycolytic process (GO:0045821) | 3.10341839 |
| 64 | nitrogen cycle metabolic process (GO:0071941) | 3.10131776 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.09876497 |
| 66 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.09566509 |
| 67 | glutamate metabolic process (GO:0006536) | 3.09340610 |
| 68 | cellular glucuronidation (GO:0052695) | 3.07982120 |
| 69 | homocysteine metabolic process (GO:0050667) | 3.07643436 |
| 70 | kynurenine metabolic process (GO:0070189) | 3.07268976 |
| 71 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.06929321 |
| 72 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.06929321 |
| 73 | reverse cholesterol transport (GO:0043691) | 3.06899428 |
| 74 | regulation of histone H3-K9 methylation (GO:0051570) | 3.06093143 |
| 75 | negative T cell selection (GO:0043383) | 3.06052893 |
| 76 | bile acid metabolic process (GO:0008206) | 3.05596891 |
| 77 | oxaloacetate metabolic process (GO:0006107) | 3.04802555 |
| 78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04421376 |
| 79 | drug transmembrane transport (GO:0006855) | 3.03109615 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.01881095 |
| 81 | acylglycerol homeostasis (GO:0055090) | 3.00877614 |
| 82 | triglyceride homeostasis (GO:0070328) | 3.00877614 |
| 83 | aspartate family amino acid catabolic process (GO:0009068) | 3.00476320 |
| 84 | glucuronate metabolic process (GO:0019585) | 2.97538707 |
| 85 | uronic acid metabolic process (GO:0006063) | 2.97538707 |
| 86 | negative thymic T cell selection (GO:0045060) | 2.96398494 |
| 87 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.95993991 |
| 88 | plasma lipoprotein particle clearance (GO:0034381) | 2.95184988 |
| 89 | Rap protein signal transduction (GO:0032486) | 2.93728708 |
| 90 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.93061024 |
| 91 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91845140 |
| 92 | indole-containing compound catabolic process (GO:0042436) | 2.91818505 |
| 93 | indolalkylamine catabolic process (GO:0046218) | 2.91818505 |
| 94 | tryptophan catabolic process (GO:0006569) | 2.91818505 |
| 95 | drug catabolic process (GO:0042737) | 2.88865429 |
| 96 | tricarboxylic acid metabolic process (GO:0072350) | 2.88504304 |
| 97 | coenzyme catabolic process (GO:0009109) | 2.87239962 |
| 98 | hepatocyte apoptotic process (GO:0097284) | 2.86760120 |
| 99 | DNA topological change (GO:0006265) | 2.86442778 |
| 100 | tryptophan metabolic process (GO:0006568) | 2.86004723 |
| 101 | cellular modified amino acid catabolic process (GO:0042219) | 2.85959296 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85814355 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 2.85210138 |
| 104 | protein-lipid complex remodeling (GO:0034368) | 2.84960065 |
| 105 | macromolecular complex remodeling (GO:0034367) | 2.84960065 |
| 106 | plasma lipoprotein particle remodeling (GO:0034369) | 2.84960065 |
| 107 | ketone body metabolic process (GO:1902224) | 2.84804100 |
| 108 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.84397293 |
| 109 | regulation of fibrinolysis (GO:0051917) | 2.83334276 |
| 110 | regulation of triglyceride catabolic process (GO:0010896) | 2.82546102 |
| 111 | fatty acid oxidation (GO:0019395) | 2.81604576 |
| 112 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.80903122 |
| 113 | establishment of chromosome localization (GO:0051303) | 2.80750063 |
| 114 | fatty acid beta-oxidation (GO:0006635) | 2.79715060 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 2.79703146 |
| 116 | low-density lipoprotein particle clearance (GO:0034383) | 2.78793768 |
| 117 | intestinal cholesterol absorption (GO:0030299) | 2.78397117 |
| 118 | lipid oxidation (GO:0034440) | 2.78067995 |
| 119 | regulation of centriole replication (GO:0046599) | 2.77685539 |
| 120 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.77654685 |
| 121 | activated T cell proliferation (GO:0050798) | 2.77579433 |
| 122 | macroautophagy (GO:0016236) | 2.76678155 |
| 123 | cholesterol efflux (GO:0033344) | 2.75417085 |
| 124 | aromatic amino acid family metabolic process (GO:0009072) | 2.73790684 |
| 125 | cellular amino acid catabolic process (GO:0009063) | 2.72317304 |
| 126 | alpha-amino acid catabolic process (GO:1901606) | 2.71470791 |
| 127 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.71149844 |
| 128 | alkaloid metabolic process (GO:0009820) | 2.70664677 |
| 129 | fatty acid catabolic process (GO:0009062) | 2.68625592 |
| 130 | mast cell activation (GO:0045576) | 2.67931315 |
| 131 | short-chain fatty acid metabolic process (GO:0046459) | 2.67892794 |
| 132 | monocarboxylic acid catabolic process (GO:0072329) | 2.66974535 |
| 133 | positive regulation of lipid catabolic process (GO:0050996) | 2.66502563 |
| 134 | regulation of regulatory T cell differentiation (GO:0045589) | 2.65706293 |
| 135 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.65485384 |
| 136 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.65485384 |
| 137 | regulation of sister chromatid segregation (GO:0033045) | 2.65485384 |
| 138 | B cell receptor signaling pathway (GO:0050853) | 2.65083868 |
| 139 | negative regulation of DNA repair (GO:0045738) | 2.64577423 |
| 140 | phospholipid efflux (GO:0033700) | 2.62737617 |
| 141 | endoderm formation (GO:0001706) | 2.62561125 |
| 142 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62300093 |
| 143 | bile acid and bile salt transport (GO:0015721) | 2.60642550 |
| 144 | T cell homeostasis (GO:0043029) | 2.60177305 |
| 145 | T cell migration (GO:0072678) | 2.59595636 |
| 146 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.59379259 |
| 147 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.59379259 |
| 148 | protein localization to kinetochore (GO:0034501) | 2.58863997 |
| 149 | phospholipid homeostasis (GO:0055091) | 2.58635184 |
| 150 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.58265431 |
| 151 | synapsis (GO:0007129) | 2.57671464 |
| 152 | negative regulation of protein activation cascade (GO:2000258) | 2.57489317 |
| 153 | dicarboxylic acid catabolic process (GO:0043649) | 2.57343627 |
| 154 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56927735 |
| 155 | leukocyte degranulation (GO:0043299) | 2.56563550 |
| 156 | ethanol oxidation (GO:0006069) | 2.55143439 |
| 157 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.54898610 |
| 158 | lipoprotein metabolic process (GO:0042157) | 2.53464978 |
| 159 | COPII vesicle coating (GO:0048208) | 2.53280451 |
| 160 | genitalia morphogenesis (GO:0035112) | 2.53142093 |
| 161 | regulation of cholesterol metabolic process (GO:0090181) | 2.53016346 |
| 162 | protein localization to chromosome, centromeric region (GO:0071459) | 2.52396180 |
| 163 | carboxylic acid catabolic process (GO:0046395) | 2.52098691 |
| 164 | organic acid catabolic process (GO:0016054) | 2.52098691 |
| 165 | negative regulation of sterol transport (GO:0032372) | 2.51951384 |
| 166 | negative regulation of cholesterol transport (GO:0032375) | 2.51951384 |
| 167 | benzene-containing compound metabolic process (GO:0042537) | 2.50699574 |
| 168 | fatty acid homeostasis (GO:0055089) | 2.49832485 |
| 169 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.49598606 |
| 170 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.49210553 |
| 171 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.49210553 |
| 172 | isotype switching (GO:0045190) | 2.49210553 |
| 173 | CENP-A containing nucleosome assembly (GO:0034080) | 2.49150382 |
| 174 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.48778634 |
| 175 | necroptotic process (GO:0070266) | 2.47931102 |
| 176 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.47199735 |
| 177 | negative regulation of sister chromatid segregation (GO:0033046) | 2.47199735 |
| 178 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.47199735 |
| 179 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.47199735 |
| 180 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.47199735 |
| 181 | neutrophil activation (GO:0042119) | 2.47143619 |
| 182 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.46784528 |
| 183 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.46327090 |
| 184 | histone H3-K36 demethylation (GO:0070544) | 2.46148003 |
| 185 | natural killer cell differentiation (GO:0001779) | 2.45963539 |
| 186 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.45728947 |
| 187 | non-recombinational repair (GO:0000726) | 2.45728947 |
| 188 | protein prenylation (GO:0018342) | 2.45568027 |
| 189 | prenylation (GO:0097354) | 2.45568027 |
| 190 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.45374284 |
| 191 | embryonic process involved in female pregnancy (GO:0060136) | 2.44322673 |
| 192 | regulation of sister chromatid cohesion (GO:0007063) | 2.44056495 |
| 193 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.43922156 |
| 194 | negative regulation of chromosome segregation (GO:0051985) | 2.42852838 |
| 195 | regulation of DNA endoreduplication (GO:0032875) | 2.40561891 |
| 196 | regulation of chromatin silencing (GO:0031935) | 2.40340336 |
| 197 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.40206045 |
| 198 | mitotic metaphase plate congression (GO:0007080) | 2.39629534 |
| 199 | positive regulation of chromosome segregation (GO:0051984) | 2.38914997 |
| 200 | heparin metabolic process (GO:0030202) | 2.37922712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.37755850 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.96298456 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.82605343 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64730439 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.99038067 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.93072767 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.66671700 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.14184003 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.96870309 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.90073194 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.85303664 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.75480005 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.71947696 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.67111526 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.43151128 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.26751036 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21994768 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.19788782 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10518288 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.07889549 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06587868 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05082662 |
| 23 | * MYB_26560356_Chip-Seq_TH2_Human | 2.00456821 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.96983496 |
| 25 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.93913518 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.93360553 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.91869462 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.86712453 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.81492173 |
| 30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.81154873 |
| 31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.81154873 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.74372877 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.71898058 |
| 34 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71132606 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68700905 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.67102017 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62981875 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.60396853 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.57901976 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57704444 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57593600 |
| 42 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53435644 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51186081 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50975149 |
| 45 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.50456756 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.49440819 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48580778 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48007821 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46165946 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45118430 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43382320 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43313655 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41132029 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40880037 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40472554 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40209101 |
| 57 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39757914 |
| 58 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.39757914 |
| 59 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39757914 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39679597 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39033742 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38327071 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37336342 |
| 64 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.35597459 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35516235 |
| 66 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31605698 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31553665 |
| 68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.31504261 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30889061 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30563759 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30454147 |
| 72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29829516 |
| 73 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29059264 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29046314 |
| 75 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28781593 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28621966 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27217954 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27036427 |
| 79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22780083 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22606565 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22404863 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22185660 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21939211 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21893073 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21600427 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20996565 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19503451 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19085652 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18117081 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17094931 |
| 91 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16815904 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15675692 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14174004 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13467770 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09947468 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08953547 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08760251 |
| 98 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08689269 |
| 99 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08634260 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08260837 |
| 101 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.07747144 |
| 102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06332622 |
| 103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06039756 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05839002 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05396182 |
| 106 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04749347 |
| 107 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03613745 |
| 108 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02640683 |
| 109 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02093603 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00673003 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00465547 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99731320 |
| 113 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.99659330 |
| 114 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.99487825 |
| 115 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99248135 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99136196 |
| 117 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98741314 |
| 118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97935053 |
| 119 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97195166 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95228885 |
| 121 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94901478 |
| 122 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94627385 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94298466 |
| 124 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.93873331 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93147727 |
| 126 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93065990 |
| 127 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92338596 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91741187 |
| 129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91262734 |
| 130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91094579 |
| 131 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90888994 |
| 132 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90844970 |
| 133 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.90732058 |
| 134 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90704038 |
| 135 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90685583 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89609075 |
| 137 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.88945034 |
| 138 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88920875 |
| 139 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87907251 |
| 140 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.87561759 |
| 141 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.87133852 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86215146 |
| 143 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85647922 |
| 144 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85349135 |
| 145 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84719370 |
| 146 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84366010 |
| 147 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83497550 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83487189 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83314933 |
| 150 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82922272 |
| 151 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82789548 |
| 152 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.82725104 |
| 153 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81940236 |
| 154 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80641861 |
| 155 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80144446 |
| 156 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79609401 |
| 157 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.79513461 |
| 158 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.79513461 |
| 159 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.78830070 |
| 160 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.77445761 |
| 161 | AR_25329375_ChIP-Seq_VCAP_Human | 0.76732607 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.76664989 |
| 163 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75972240 |
| 164 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75860367 |
| 165 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75611060 |
| 166 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.74366963 |
| 167 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.73436146 |
| 168 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.72638192 |
| 169 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72193813 |
| 170 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71813432 |
| 171 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.71721833 |
| 172 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.71599126 |
| 173 | P300_19829295_ChIP-Seq_ESCs_Human | 0.70837991 |
| 174 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70282573 |
| 175 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70161051 |
| 176 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.69663416 |
| 177 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68717735 |
| 178 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.67638966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.80876861 |
| 2 | MP0005360_urolithiasis | 5.14641960 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.26032949 |
| 4 | MP0005365_abnormal_bile_salt | 4.16646134 |
| 5 | MP0008057_abnormal_DNA_replication | 3.83627833 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.50593928 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.42200953 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 3.08126462 |
| 9 | MP0003195_calcinosis | 3.02048889 |
| 10 | MP0003252_abnormal_bile_duct | 3.00736218 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.90891068 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.84717981 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.67472219 |
| 14 | MP0005083_abnormal_biliary_tract | 2.56137596 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.49014981 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.45133007 |
| 17 | MP0002009_preneoplasia | 2.43844511 |
| 18 | MP0000372_irregular_coat_pigmentation | 2.43659993 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.42082980 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.34001858 |
| 21 | MP0005332_abnormal_amino_acid | 2.31947618 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.31853355 |
| 23 | MP0003828_pulmonary_edema | 2.31531473 |
| 24 | MP0005671_abnormal_response_to | 2.27132434 |
| 25 | MP0000015_abnormal_ear_pigmentation | 2.26660160 |
| 26 | MP0008877_abnormal_DNA_methylation | 2.22922237 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 2.21343946 |
| 28 | MP0000569_abnormal_digit_pigmentation | 2.19153012 |
| 29 | MP0004043_abnormal_pH_regulation | 2.17321299 |
| 30 | MP0010094_abnormal_chromosome_stability | 2.16395706 |
| 31 | MP0004381_abnormal_hair_follicle | 2.12492661 |
| 32 | MP0002909_abnormal_adrenal_gland | 2.03363876 |
| 33 | MP0000013_abnormal_adipose_tissue | 2.02438215 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.88345816 |
| 35 | MP0009840_abnormal_foam_cell | 1.88073481 |
| 36 | MP0010307_abnormal_tumor_latency | 1.86210447 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.83199463 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.81952678 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.79850466 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.79399954 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.75951202 |
| 42 | MP0002398_abnormal_bone_marrow | 1.75077779 |
| 43 | MP0003077_abnormal_cell_cycle | 1.74987620 |
| 44 | MP0002102_abnormal_ear_morphology | 1.73300354 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.70410347 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.68789362 |
| 47 | MP0004130_abnormal_muscle_cell | 1.67753746 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.65384295 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.61993448 |
| 50 | MP0000609_abnormal_liver_physiology | 1.61957914 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.59779650 |
| 52 | MP0003868_abnormal_feces_composition | 1.59245708 |
| 53 | MP0000604_amyloidosis | 1.59235622 |
| 54 | MP0001800_abnormal_humoral_immune | 1.54960175 |
| 55 | MP0003718_maternal_effect | 1.54488080 |
| 56 | MP0001819_abnormal_immune_cell | 1.52736958 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.52382841 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.50215954 |
| 59 | MP0001851_eye_inflammation | 1.50173495 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.50130317 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.49704663 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.48468594 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.44939603 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.43883335 |
| 65 | MP0008004_abnormal_stomach_pH | 1.43619667 |
| 66 | MP0002722_abnormal_immune_system | 1.43079230 |
| 67 | MP0001730_embryonic_growth_arrest | 1.40540570 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40293066 |
| 69 | MP0002723_abnormal_immune_serum | 1.39719915 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.39225080 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.37644536 |
| 72 | MP0003436_decreased_susceptibility_to | 1.36455552 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 1.35406049 |
| 74 | MP0005535_abnormal_body_temperature | 1.33465858 |
| 75 | MP0003329_amyloid_beta_deposits | 1.32926913 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.32357109 |
| 77 | MP0009697_abnormal_copulation | 1.32348234 |
| 78 | MP0002452_abnormal_antigen_presenting | 1.29328239 |
| 79 | MP0000716_abnormal_immune_system | 1.24571546 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 1.23201456 |
| 81 | MP0002419_abnormal_innate_immunity | 1.22294868 |
| 82 | MP0008260_abnormal_autophagy | 1.21639663 |
| 83 | MP0005174_abnormal_tail_pigmentation | 1.21167914 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.20825157 |
| 85 | MP0001756_abnormal_urination | 1.17084785 |
| 86 | MP0002006_tumorigenesis | 1.15518756 |
| 87 | MP0001944_abnormal_pancreas_morphology | 1.14890162 |
| 88 | MP0001672_abnormal_embryogenesis/_devel | 1.13458137 |
| 89 | MP0005380_embryogenesis_phenotype | 1.13458137 |
| 90 | MP0002429_abnormal_blood_cell | 1.12849377 |
| 91 | MP0008438_abnormal_cutaneous_collagen | 1.11262755 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 1.09514901 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 1.09056080 |
| 94 | MP0000350_abnormal_cell_proliferation | 1.08361174 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 1.07183885 |
| 96 | MP0002405_respiratory_system_inflammati | 1.06481837 |
| 97 | MP0002693_abnormal_pancreas_physiology | 1.05286078 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 1.04401718 |
| 99 | MP0001765_abnormal_ion_homeostasis | 1.02511998 |
| 100 | MP0003172_abnormal_lysosome_physiology | 1.02157209 |
| 101 | MP0008058_abnormal_DNA_repair | 1.01982081 |
| 102 | MP0001790_abnormal_immune_system | 1.01538211 |
| 103 | MP0005387_immune_system_phenotype | 1.01538211 |
| 104 | MP0000371_diluted_coat_color | 0.99248154 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.97733470 |
| 106 | MP0003690_abnormal_glial_cell | 0.97553217 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.97081434 |
| 108 | MP0003950_abnormal_plasma_membrane | 0.96740544 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 0.95889661 |
| 110 | MP0005025_abnormal_response_to | 0.95736629 |
| 111 | MP0003984_embryonic_growth_retardation | 0.95613185 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.94539752 |
| 113 | MP0005310_abnormal_salivary_gland | 0.94453571 |
| 114 | MP0004859_abnormal_synaptic_plasticity | 0.93809534 |
| 115 | MP0004147_increased_porphyrin_level | 0.93133673 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.92509066 |
| 117 | MP0002896_abnormal_bone_mineralization | 0.90262284 |
| 118 | MP0002086_abnormal_extraembryonic_tissu | 0.89954488 |
| 119 | MP0009785_altered_susceptibility_to | 0.89687064 |
| 120 | MP0004947_skin_inflammation | 0.88385108 |
| 121 | MP0002928_abnormal_bile_duct | 0.88005317 |
| 122 | MP0004270_analgesia | 0.86517254 |
| 123 | MP0002254_reproductive_system_inflammat | 0.86175865 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.85438873 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.85416551 |
| 126 | MP0006054_spinal_hemorrhage | 0.85234122 |
| 127 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84829414 |
| 128 | MP0003303_peritoneal_inflammation | 0.84496455 |
| 129 | MP0002148_abnormal_hypersensitivity_rea | 0.84377562 |
| 130 | MP0000428_abnormal_craniofacial_morphol | 0.84109287 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.83469799 |
| 132 | MP0003075_altered_response_to | 0.83246543 |
| 133 | MP0005334_abnormal_fat_pad | 0.81915808 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.81780601 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.81536820 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.81386413 |
| 137 | MP0003186_abnormal_redox_activity | 0.80812082 |
| 138 | MP0004858_abnormal_nervous_system | 0.80547790 |
| 139 | MP0005408_hypopigmentation | 0.80283440 |
| 140 | MP0010155_abnormal_intestine_physiology | 0.80024187 |
| 141 | MP0005621_abnormal_cell_physiology | 0.79931522 |
| 142 | MP0005448_abnormal_energy_balance | 0.79150680 |
| 143 | MP0000598_abnormal_liver_morphology | 0.78910708 |
| 144 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77295264 |
| 145 | MP0002095_abnormal_skin_pigmentation | 0.76823376 |
| 146 | MP0003633_abnormal_nervous_system | 0.76529718 |
| 147 | MP0003448_altered_tumor_morphology | 0.75871373 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.75583277 |
| 149 | MP0009642_abnormal_blood_homeostasis | 0.75412054 |
| 150 | MP0005397_hematopoietic_system_phenotyp | 0.75145947 |
| 151 | MP0001545_abnormal_hematopoietic_system | 0.75145947 |
| 152 | MP0001501_abnormal_sleep_pattern | 0.75078201 |
| 153 | MP0009764_decreased_sensitivity_to | 0.74032791 |
| 154 | MP0003941_abnormal_skin_development | 0.73862806 |
| 155 | MP0003953_abnormal_hormone_level | 0.73805855 |
| 156 | MP0002822_catalepsy | 0.73471132 |
| 157 | MP0006036_abnormal_mitochondrial_physio | 0.73434768 |
| 158 | MP0001764_abnormal_homeostasis | 0.73162133 |
| 159 | MP0002084_abnormal_developmental_patter | 0.72885893 |
| 160 | MP0001697_abnormal_embryo_size | 0.72699000 |
| 161 | MP0002971_abnormal_brown_adipose | 0.71786855 |
| 162 | MP0005666_abnormal_adipose_tissue | 0.71242012 |
| 163 | MP0005275_abnormal_skin_tensile | 0.70877071 |
| 164 | MP0001853_heart_inflammation | 0.70569947 |
| 165 | MP0001299_abnormal_eye_distance/ | 0.70487056 |
| 166 | MP0000427_abnormal_hair_cycle | 0.68746577 |
| 167 | MP0005166_decreased_susceptibility_to | 0.66753896 |
| 168 | MP0005670_abnormal_white_adipose | 0.66656883 |
| 169 | MP0002090_abnormal_vision | 0.65618477 |
| 170 | MP0009384_cardiac_valve_regurgitation | 0.64359524 |
| 171 | MP0005375_adipose_tissue_phenotype | 0.63683673 |
| 172 | MP0008469_abnormal_protein_level | 0.62904199 |
| 173 | MP0003283_abnormal_digestive_organ | 0.62608447 |
| 174 | MP0002136_abnormal_kidney_physiology | 0.62262201 |
| 175 | MP0000639_abnormal_adrenal_gland | 0.61795659 |
| 176 | MP0002735_abnormal_chemical_nociception | 0.61080706 |
| 177 | MP0003959_abnormal_lean_body | 0.60840711 |
| 178 | MP0009763_increased_sensitivity_to | 0.60581944 |
| 179 | MP0002733_abnormal_thermal_nociception | 0.59907684 |
| 180 | MP0001533_abnormal_skeleton_physiology | 0.59657244 |
| 181 | MP0005646_abnormal_pituitary_gland | 0.59231856 |
| 182 | MP0000538_abnormal_urinary_bladder | 0.58493447 |
| 183 | MP0002168_other_aberrant_phenotype | 0.57890938 |
| 184 | MP0009765_abnormal_xenobiotic_induced | 0.57517568 |
| 185 | MP0003724_increased_susceptibility_to | 0.56898362 |
| 186 | MP0001177_atelectasis | 0.56337930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.65046999 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.58865886 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.57496973 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.28649628 |
| 5 | Xanthomatosis (HP:0000991) | 4.21295801 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.16041207 |
| 7 | Hypoglycemic coma (HP:0001325) | 4.07709797 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90993872 |
| 9 | Ketoacidosis (HP:0001993) | 3.76525001 |
| 10 | Ketosis (HP:0001946) | 3.62228594 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 3.48841382 |
| 12 | Volvulus (HP:0002580) | 3.47266743 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.46442913 |
| 14 | Complement deficiency (HP:0004431) | 3.29016987 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.20290119 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.15058978 |
| 17 | Abnormality of T cells (HP:0002843) | 3.12269750 |
| 18 | Gonadal dysgenesis (HP:0000133) | 3.10167707 |
| 19 | Epidermoid cyst (HP:0200040) | 3.05180647 |
| 20 | Embryonal renal neoplasm (HP:0011794) | 3.04720755 |
| 21 | Papillary thyroid carcinoma (HP:0002895) | 3.01037755 |
| 22 | Acute myeloid leukemia (HP:0004808) | 2.99878219 |
| 23 | Hyperammonemia (HP:0001987) | 2.99159118 |
| 24 | Gout (HP:0001997) | 2.95531269 |
| 25 | Prolonged partial thromboplastin time (HP:0003645) | 2.92307237 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 2.91831259 |
| 27 | Abnormality of B cell number (HP:0010975) | 2.89883462 |
| 28 | Hypolipoproteinemia (HP:0010981) | 2.88393406 |
| 29 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.88273375 |
| 30 | Eczematoid dermatitis (HP:0000976) | 2.87815538 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 2.87087833 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.83175191 |
| 33 | Abnormality of the lumbar spine (HP:0100712) | 2.82671110 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 2.82112524 |
| 35 | Abnormality of oral frenula (HP:0000190) | 2.81321374 |
| 36 | Fat malabsorption (HP:0002630) | 2.78310452 |
| 37 | B lymphocytopenia (HP:0010976) | 2.76477037 |
| 38 | Skin nodule (HP:0200036) | 2.75787942 |
| 39 | IgM deficiency (HP:0002850) | 2.75010929 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.73928362 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 2.73847335 |
| 42 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.70457119 |
| 43 | Hypoalphalipoproteinemia (HP:0003233) | 2.68956014 |
| 44 | Gonadotropin excess (HP:0000837) | 2.66572847 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.64800385 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.64800385 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59358307 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58889619 |
| 49 | Pheochromocytoma (HP:0002666) | 2.58415305 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.58052491 |
| 51 | Abnormal platelet volume (HP:0011876) | 2.57692787 |
| 52 | Renal cortical cysts (HP:0000803) | 2.57373036 |
| 53 | Hyperglycinuria (HP:0003108) | 2.56146516 |
| 54 | Abnormality of chromosome stability (HP:0003220) | 2.55909759 |
| 55 | Stomatitis (HP:0010280) | 2.55068242 |
| 56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.54183730 |
| 57 | Ocular albinism (HP:0001107) | 2.53894522 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.52993161 |
| 59 | Abnormality of glycine metabolism (HP:0010895) | 2.52993161 |
| 60 | Abnormality of the prostate (HP:0008775) | 2.52823565 |
| 61 | Sensorimotor neuropathy (HP:0007141) | 2.52325440 |
| 62 | Autoimmune hemolytic anemia (HP:0001890) | 2.51488722 |
| 63 | Hyperglycinemia (HP:0002154) | 2.51395568 |
| 64 | Increased mean platelet volume (HP:0011877) | 2.50367335 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.49358611 |
| 66 | Combined immunodeficiency (HP:0005387) | 2.49284430 |
| 67 | Papilledema (HP:0001085) | 2.47992627 |
| 68 | Prostate neoplasm (HP:0100787) | 2.47547723 |
| 69 | Symptomatic seizures (HP:0011145) | 2.47206709 |
| 70 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.47163175 |
| 71 | Hypoplasia of the fovea (HP:0007750) | 2.47163175 |
| 72 | Chromsome breakage (HP:0040012) | 2.44694955 |
| 73 | Abnormal auditory evoked potentials (HP:0006958) | 2.44087723 |
| 74 | Facial hemangioma (HP:0000329) | 2.44067666 |
| 75 | Thoracolumbar scoliosis (HP:0002944) | 2.43214935 |
| 76 | Thyroid carcinoma (HP:0002890) | 2.42851098 |
| 77 | Hyperglycemia (HP:0003074) | 2.37557994 |
| 78 | Iris hypopigmentation (HP:0007730) | 2.36725916 |
| 79 | Capillary hemangiomas (HP:0005306) | 2.36260989 |
| 80 | Protuberant abdomen (HP:0001538) | 2.35970259 |
| 81 | Mitral stenosis (HP:0001718) | 2.34748108 |
| 82 | Stomach cancer (HP:0012126) | 2.33774594 |
| 83 | Abnormality of complement system (HP:0005339) | 2.32399797 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.32281023 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32281023 |
| 86 | Recurrent abscess formation (HP:0002722) | 2.29472657 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.28469306 |
| 88 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.28197750 |
| 89 | Neuroendocrine neoplasm (HP:0100634) | 2.27643846 |
| 90 | Abnormality of the fovea (HP:0000493) | 2.26151921 |
| 91 | Recurrent bacterial skin infections (HP:0005406) | 2.26003154 |
| 92 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.25747882 |
| 93 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25204912 |
| 94 | Abnormality of methionine metabolism (HP:0010901) | 2.23859688 |
| 95 | Dysostosis multiplex (HP:0000943) | 2.23462591 |
| 96 | Hyperbilirubinemia (HP:0002904) | 2.23300653 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.21186393 |
| 98 | Hepatocellular carcinoma (HP:0001402) | 2.20307196 |
| 99 | Dyschromatopsia (HP:0007641) | 2.19524937 |
| 100 | Conjunctival telangiectasia (HP:0000524) | 2.16502559 |
| 101 | Severe combined immunodeficiency (HP:0004430) | 2.16430281 |
| 102 | Ovarian neoplasm (HP:0100615) | 2.15952487 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 2.15361448 |
| 104 | Resting tremor (HP:0002322) | 2.14997616 |
| 105 | Abnormality of nucleobase metabolism (HP:0010932) | 2.14257861 |
| 106 | Myocardial infarction (HP:0001658) | 2.12417763 |
| 107 | Ankyloglossia (HP:0010296) | 2.11785246 |
| 108 | Biliary tract neoplasm (HP:0100574) | 2.10371381 |
| 109 | Retrobulbar optic neuritis (HP:0100654) | 2.08720875 |
| 110 | Optic neuritis (HP:0100653) | 2.08720875 |
| 111 | Abnormal lung lobation (HP:0002101) | 2.08661619 |
| 112 | Encephalitis (HP:0002383) | 2.07925236 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07335025 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07335025 |
| 115 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07335025 |
| 116 | IgG deficiency (HP:0004315) | 2.07007760 |
| 117 | Abnormality of macrophages (HP:0004311) | 2.06762771 |
| 118 | Recurrent viral infections (HP:0004429) | 2.06511648 |
| 119 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.06049520 |
| 120 | Albinism (HP:0001022) | 2.05197085 |
| 121 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03446577 |
| 122 | Hypercholesterolemia (HP:0003124) | 2.02655800 |
| 123 | Abnormal gallbladder morphology (HP:0012437) | 2.02231836 |
| 124 | Panhypogammaglobulinemia (HP:0003139) | 2.01125706 |
| 125 | Myositis (HP:0100614) | 2.01102343 |
| 126 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.00810181 |
| 127 | Spastic diplegia (HP:0001264) | 1.99896543 |
| 128 | Chronic diarrhea (HP:0002028) | 1.99754091 |
| 129 | Testicular neoplasm (HP:0010788) | 1.99019386 |
| 130 | Irritability (HP:0000737) | 1.98530734 |
| 131 | Intestinal atresia (HP:0011100) | 1.95453949 |
| 132 | Joint hemorrhage (HP:0005261) | 1.94767988 |
| 133 | Gingival bleeding (HP:0000225) | 1.93618551 |
| 134 | Recurrent fungal infections (HP:0002841) | 1.91963518 |
| 135 | Periodontitis (HP:0000704) | 1.91886316 |
| 136 | Hyperuricemia (HP:0002149) | 1.90929623 |
| 137 | Increased purine levels (HP:0004368) | 1.90929623 |
| 138 | Metabolic acidosis (HP:0001942) | 1.90614367 |
| 139 | Systemic lupus erythematosus (HP:0002725) | 1.90465408 |
| 140 | Deviation of the thumb (HP:0009603) | 1.90070114 |
| 141 | Keratoconjunctivitis sicca (HP:0001097) | 1.90038244 |
| 142 | Neoplasm of the colon (HP:0100273) | 1.89939051 |
| 143 | Abnormal tarsal ossification (HP:0008369) | 1.89700046 |
| 144 | Neonatal onset (HP:0003623) | 1.89237747 |
| 145 | Neoplasm of the small intestine (HP:0100833) | 1.88856397 |
| 146 | Abnormality of male internal genitalia (HP:0000022) | 1.88805006 |
| 147 | Proximal placement of thumb (HP:0009623) | 1.88636904 |
| 148 | Clitoromegaly (HP:0000057) | 1.88526069 |
| 149 | Cerebral hemorrhage (HP:0001342) | 1.88117662 |
| 150 | Long toe (HP:0010511) | 1.84499937 |
| 151 | Acanthocytosis (HP:0001927) | 1.83949942 |
| 152 | Central scotoma (HP:0000603) | 1.83720238 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.81779628 |
| 154 | Pancreatitis (HP:0001733) | 1.81714458 |
| 155 | Steatorrhea (HP:0002570) | 1.81677926 |
| 156 | IgA deficiency (HP:0002720) | 1.80698196 |
| 157 | Joint swelling (HP:0001386) | 1.79837429 |
| 158 | Conjunctival hamartoma (HP:0100780) | 1.79696422 |
| 159 | Cholelithiasis (HP:0001081) | 1.79313291 |
| 160 | Anhidrosis (HP:0000970) | 1.78831384 |
| 161 | Myelodysplasia (HP:0002863) | 1.78727121 |
| 162 | Lymphoma (HP:0002665) | 1.78496055 |
| 163 | Keratoconjunctivitis (HP:0001096) | 1.78193954 |
| 164 | Arterial thrombosis (HP:0004420) | 1.78161986 |
| 165 | Patchy hypopigmentation of hair (HP:0011365) | 1.77635365 |
| 166 | Orchitis (HP:0100796) | 1.76681631 |
| 167 | Abnormality of vitamin B metabolism (HP:0004340) | 1.75751356 |
| 168 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74815206 |
| 169 | Lower limb hyperreflexia (HP:0002395) | 1.73284551 |
| 170 | Epistaxis (HP:0000421) | 1.73191859 |
| 171 | Abnormality of serum amino acid levels (HP:0003112) | 1.72994817 |
| 172 | Abnormality of the columella (HP:0009929) | 1.72689038 |
| 173 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.71044042 |
| 174 | Methylmalonic acidemia (HP:0002912) | 1.70828918 |
| 175 | Lymphopenia (HP:0001888) | 1.70575039 |
| 176 | Oligomenorrhea (HP:0000876) | 1.70320736 |
| 177 | Alkalosis (HP:0001948) | 1.70275714 |
| 178 | Rhabdomyosarcoma (HP:0002859) | 1.69984871 |
| 179 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.68615909 |
| 180 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.68615909 |
| 181 | Increased CSF protein (HP:0002922) | 1.65937892 |
| 182 | Myoglobinuria (HP:0002913) | 1.65915029 |
| 183 | Amyloidosis (HP:0011034) | 1.65848856 |
| 184 | Late onset (HP:0003584) | 1.63970070 |
| 185 | Delayed CNS myelination (HP:0002188) | 1.63710793 |
| 186 | Acute hepatic failure (HP:0006554) | 1.61505700 |
| 187 | Esophageal varix (HP:0002040) | 1.60853057 |
| 188 | Tetraplegia (HP:0002445) | 1.60819620 |
| 189 | Global brain atrophy (HP:0002283) | 1.60738516 |
| 190 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.60513999 |
| 191 | Death in childhood (HP:0003819) | 1.60125748 |
| 192 | Hypokalemic alkalosis (HP:0001949) | 1.58823731 |
| 193 | Abdominal distention (HP:0003270) | 1.58536010 |
| 194 | Status epilepticus (HP:0002133) | 1.57658103 |
| 195 | Abnormal foot bone ossification (HP:0010675) | 1.56521247 |
| 196 | Abnormality of the gallbladder (HP:0005264) | 1.55607746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.56557129 |
| 2 | MAP3K2 | 3.29393115 |
| 3 | FRK | 3.11122150 |
| 4 | ACVR1B | 2.92166387 |
| 5 | INSRR | 2.83083353 |
| 6 | SCYL2 | 2.72090436 |
| 7 | NUAK1 | 2.64246771 |
| 8 | ERN1 | 2.58759856 |
| 9 | BCKDK | 2.47387429 |
| 10 | CAMKK2 | 2.29509635 |
| 11 | EIF2AK3 | 2.29164578 |
| 12 | NTRK3 | 2.22073406 |
| 13 | MAP4K1 | 2.14678732 |
| 14 | TRIB3 | 2.13681500 |
| 15 | KSR2 | 2.06229344 |
| 16 | TEC | 1.98306296 |
| 17 | BMPR2 | 1.95355410 |
| 18 | PKN2 | 1.94839273 |
| 19 | MKNK1 | 1.94460351 |
| 20 | SIK1 | 1.85782931 |
| 21 | MAP2K4 | 1.84008888 |
| 22 | TTK | 1.81807891 |
| 23 | CAMKK1 | 1.73796001 |
| 24 | CDK6 | 1.69907766 |
| 25 | PLK4 | 1.69141502 |
| 26 | FGFR4 | 1.68681829 |
| 27 | STK3 | 1.67230105 |
| 28 | NTRK1 | 1.59631216 |
| 29 | LMTK2 | 1.57830948 |
| 30 | SIK3 | 1.55351156 |
| 31 | WEE1 | 1.55295932 |
| 32 | FES | 1.54361870 |
| 33 | RET | 1.53222956 |
| 34 | PTK6 | 1.51558613 |
| 35 | RIPK1 | 1.49559591 |
| 36 | MKNK2 | 1.48728003 |
| 37 | ZAP70 | 1.47368143 |
| 38 | PAK3 | 1.46659957 |
| 39 | PDGFRA | 1.45760646 |
| 40 | PDK3 | 1.43773340 |
| 41 | PDK4 | 1.43773340 |
| 42 | PRKCH | 1.43494023 |
| 43 | NEK9 | 1.42246049 |
| 44 | TAOK3 | 1.41769899 |
| 45 | MAP3K9 | 1.41224358 |
| 46 | JAK1 | 1.39450115 |
| 47 | BRD4 | 1.38124720 |
| 48 | MINK1 | 1.32626245 |
| 49 | TNIK | 1.31868150 |
| 50 | ERBB4 | 1.28766536 |
| 51 | WNK4 | 1.28429023 |
| 52 | PRKD3 | 1.25498590 |
| 53 | TRIM28 | 1.24597299 |
| 54 | NLK | 1.23330736 |
| 55 | MST1R | 1.19380336 |
| 56 | DAPK2 | 1.14877781 |
| 57 | RIPK4 | 1.13969604 |
| 58 | WNK3 | 1.13644383 |
| 59 | PLK3 | 1.13290134 |
| 60 | MAP2K1 | 1.13029209 |
| 61 | FER | 1.11897306 |
| 62 | YES1 | 1.11516807 |
| 63 | GRK6 | 1.11308588 |
| 64 | JAK2 | 1.10952269 |
| 65 | JAK3 | 1.10425541 |
| 66 | MAP3K4 | 1.07031404 |
| 67 | SGK3 | 1.06931631 |
| 68 | PBK | 1.06508162 |
| 69 | SYK | 1.06402455 |
| 70 | PIM1 | 1.05416113 |
| 71 | FGFR3 | 1.04527415 |
| 72 | PDK2 | 1.04242522 |
| 73 | BTK | 1.00229772 |
| 74 | PAK6 | 0.94288141 |
| 75 | CSK | 0.93668955 |
| 76 | MAP3K3 | 0.92836771 |
| 77 | MAP3K1 | 0.91904557 |
| 78 | PDPK1 | 0.91372762 |
| 79 | STK10 | 0.91012603 |
| 80 | PDK1 | 0.90341843 |
| 81 | MARK3 | 0.89510670 |
| 82 | MAP4K2 | 0.88326559 |
| 83 | LATS1 | 0.87898453 |
| 84 | FGFR2 | 0.87813564 |
| 85 | CDK4 | 0.87736717 |
| 86 | NEK6 | 0.87567475 |
| 87 | PTK2 | 0.86034476 |
| 88 | PRPF4B | 0.85538626 |
| 89 | WNK1 | 0.85228252 |
| 90 | TAF1 | 0.84982709 |
| 91 | CDC7 | 0.84966046 |
| 92 | EPHA3 | 0.83733388 |
| 93 | STK4 | 0.83158517 |
| 94 | EIF2AK2 | 0.81776928 |
| 95 | MAP3K12 | 0.81583651 |
| 96 | FGR | 0.79947982 |
| 97 | SGK2 | 0.79762586 |
| 98 | DDR2 | 0.79229281 |
| 99 | TGFBR2 | 0.78689773 |
| 100 | ERBB3 | 0.77798876 |
| 101 | FLT3 | 0.76140596 |
| 102 | NEK1 | 0.75689424 |
| 103 | KSR1 | 0.74391739 |
| 104 | MAP3K13 | 0.72788552 |
| 105 | LCK | 0.71486248 |
| 106 | CDK12 | 0.71445093 |
| 107 | LYN | 0.70687073 |
| 108 | HCK | 0.70295380 |
| 109 | OXSR1 | 0.69754463 |
| 110 | MST4 | 0.69585287 |
| 111 | SGK494 | 0.69527661 |
| 112 | SGK223 | 0.69527661 |
| 113 | CAMK1D | 0.68819326 |
| 114 | ITK | 0.66998097 |
| 115 | ABL2 | 0.66916837 |
| 116 | LIMK1 | 0.65510499 |
| 117 | MAP3K14 | 0.62806561 |
| 118 | TYK2 | 0.62572107 |
| 119 | LRRK2 | 0.61297817 |
| 120 | IGF1R | 0.59510025 |
| 121 | CHEK2 | 0.59370430 |
| 122 | MATK | 0.59270267 |
| 123 | STK24 | 0.58525313 |
| 124 | BMPR1B | 0.58308007 |
| 125 | MAP2K7 | 0.58303312 |
| 126 | MELK | 0.57362541 |
| 127 | MAP2K2 | 0.56617481 |
| 128 | ARAF | 0.56038534 |
| 129 | TNK2 | 0.56008590 |
| 130 | BRSK2 | 0.55960424 |
| 131 | RPS6KA4 | 0.55934943 |
| 132 | GRK5 | 0.54919828 |
| 133 | HIPK2 | 0.54287233 |
| 134 | SRPK1 | 0.53975653 |
| 135 | ZAK | 0.53576177 |
| 136 | PRKACG | 0.53180591 |
| 137 | PRKAA2 | 0.53108300 |
| 138 | TRPM7 | 0.52910117 |
| 139 | PDGFRB | 0.52699558 |
| 140 | MAP2K3 | 0.52662676 |
| 141 | ALK | 0.51858979 |
| 142 | TESK1 | 0.51821758 |
| 143 | ATM | 0.51421461 |
| 144 | PLK2 | 0.50968246 |
| 145 | IKBKE | 0.48838759 |
| 146 | CDK5 | 0.48765672 |
| 147 | KIT | 0.48600484 |
| 148 | CHEK1 | 0.48255130 |
| 149 | PRKCE | 0.48179873 |
| 150 | CAMK2G | 0.48112104 |
| 151 | TSSK6 | 0.47952569 |
| 152 | CSNK1G2 | 0.47159523 |
| 153 | ATR | 0.47130718 |
| 154 | STK38 | 0.46030317 |
| 155 | MAP3K7 | 0.45699754 |
| 156 | PRKAA1 | 0.45473562 |
| 157 | MET | 0.45068989 |
| 158 | PRKCG | 0.44063025 |
| 159 | RAF1 | 0.43642286 |
| 160 | EGFR | 0.42993974 |
| 161 | PIK3CG | 0.42613430 |
| 162 | TBK1 | 0.42359080 |
| 163 | RPS6KA2 | 0.40748692 |
| 164 | MAP2K6 | 0.40331399 |
| 165 | PRKCZ | 0.39995188 |
| 166 | PLK1 | 0.39109462 |
| 167 | PRKCQ | 0.39074442 |
| 168 | IRAK4 | 0.38226181 |
| 169 | GSK3A | 0.35986716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.40300154 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.95289450 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.76327137 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48669259 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.39128938 |
| 6 | Cell cycle_Homo sapiens_hsa04110 | 2.36956615 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.35989765 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25908952 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25214245 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22818606 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14628929 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12484922 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.12293054 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09022961 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.08320129 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05043666 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01807608 |
| 18 | Platelet activation_Homo sapiens_hsa04611 | 1.99706351 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96734721 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.95345602 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87898708 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.79142185 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.78775193 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.77143935 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.74318401 |
| 26 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.71351455 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68674904 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65647881 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64809450 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64427645 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63578589 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63013162 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59909025 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.59195445 |
| 35 | Thyroid cancer_Homo sapiens_hsa05216 | 1.58669780 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57191740 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.55578815 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.55006117 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.53351871 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.52887474 |
| 41 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.51970293 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50087206 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47869469 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.46450685 |
| 45 | Prostate cancer_Homo sapiens_hsa05215 | 1.45154070 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44766407 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43693265 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42968580 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42554423 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40770339 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36674684 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35222245 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33304162 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33072833 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30593293 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26886417 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.26591380 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 1.26579911 |
| 59 | RNA transport_Homo sapiens_hsa03013 | 1.22418672 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21939587 |
| 61 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.20040953 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.18957336 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18006070 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17675938 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17504207 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 1.16109823 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13267356 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11892662 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11765688 |
| 70 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.11108155 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 1.09673016 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04533245 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02709746 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02556455 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02452753 |
| 76 | Protein export_Homo sapiens_hsa03060 | 1.02449333 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01491308 |
| 78 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00976023 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.99960838 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99189726 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98418850 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98328964 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97862763 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96809873 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96139207 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95019971 |
| 87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93572534 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91627043 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91341015 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.90803635 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87177019 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.86793003 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85678515 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85492731 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84024762 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83477312 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82942422 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80102146 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79045000 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78625755 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78514913 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78440014 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77250408 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76044576 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.75863216 |
| 106 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75554789 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74802269 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.73802681 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73262116 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73176767 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72299291 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72213507 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71715297 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.71194243 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70557658 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70211731 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.69431866 |
| 118 | Allograft rejection_Homo sapiens_hsa05330 | 0.69313355 |
| 119 | Tuberculosis_Homo sapiens_hsa05152 | 0.69069395 |
| 120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68946565 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.68710295 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68213399 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.67847032 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67048182 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66017502 |
| 126 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65386187 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63351175 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63207149 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63088293 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62370223 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.62182301 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62128745 |
| 133 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62093858 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.61822400 |
| 135 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61238110 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61110624 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60188833 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.59067323 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59047922 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57110567 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57031665 |
| 142 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55998357 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55490344 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55282886 |
| 145 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53991122 |
| 146 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52416011 |
| 147 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51453534 |
| 148 | Spliceosome_Homo sapiens_hsa03040 | 0.50681823 |
| 149 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50552113 |
| 150 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50443033 |
| 151 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49493760 |
| 152 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48289679 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48068760 |
| 154 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47903886 |
| 155 | Malaria_Homo sapiens_hsa05144 | 0.47323105 |
| 156 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46758402 |
| 157 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46342832 |
| 158 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43480319 |
| 159 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42719295 |
| 160 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42583783 |
| 161 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42315067 |
| 162 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41516697 |
| 163 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39475216 |
| 164 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38403972 |
| 165 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38330604 |
| 166 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38319615 |
| 167 | Melanoma_Homo sapiens_hsa05218 | 0.36339022 |
| 168 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34728104 |
| 169 | Lysine degradation_Homo sapiens_hsa00310 | 0.33205794 |
| 170 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32932096 |
| 171 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31506828 |
| 172 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30867783 |
| 173 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30657607 |
| 174 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29478549 |
| 175 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29056177 |
| 176 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29003085 |
| 177 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28031256 |
| 178 | Cocaine addiction_Homo sapiens_hsa05030 | 0.26347105 |
| 179 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26138697 |
| 180 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.25633627 |
| 181 | Phagosome_Homo sapiens_hsa04145 | 0.24820960 |
| 182 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22292153 |
| 183 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21027080 |
| 184 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20976337 |
| 185 | Renin secretion_Homo sapiens_hsa04924 | 0.20635179 |
| 186 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20296501 |
| 187 | Amoebiasis_Homo sapiens_hsa05146 | 0.19005213 |
| 188 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18872463 |
| 189 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18861219 |
| 190 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18718494 |

